To assess possible areas of improvement, you will complete an assessment that asks to what extent you or your practice:
- Uses a standardized process to confirm maternal RSV vaccination status before newborn discharge
- Coordinates care across settings with defined roles for assessing RSV risk, eligibility, and referral, including for high-risk children entering their second RSV season
- Administers RSV monoclonal antibodies (nirsevimab or clesrovimab) according to current ACIP/AAP recommendations
- incorporates RSV risk assessment, immunization status, clinical decision support, and documentation into your electronic health record
- Introduces workflows to reduce delays between birth (or well-child visit), eligibility determination, and administration of RSV preventive therapy
- Ensures enrollment in the Vaccines for Children (VFC) program and other financing pathways to support access to RSV preventive therapies
You will receive a report card that summarizes your or your practice’s performance relative to areas assessed. This serves as your baseline and guides development of your personalized action items.